Growth Metrics

Pediatrix Medical (MD) Equity Average (2016 - 2026)

Pediatrix Medical (MD) has disclosed Equity Average for 16 consecutive years, with $878.3 million as the latest value for Q4 2025.

  • Quarterly Equity Average rose 17.3% to $878.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $878.3 million through Dec 2025, up 17.3% year-over-year, with the annual reading at $815.4 million for FY2025, 1.04% up from the prior year.
  • Equity Average for Q4 2025 was $878.3 million at Pediatrix Medical, up from $862.2 million in the prior quarter.
  • The five-year high for Equity Average was $955.2 million in Q3 2023, with the low at $719.5 million in Q3 2024.
  • Average Equity Average over 5 years is $842.0 million, with a median of $856.9 million recorded in 2022.
  • The sharpest move saw Equity Average crashed 49.28% in 2021, then grew 19.84% in 2025.
  • Over 5 years, Equity Average stood at $871.2 million in 2021, then rose by 0.46% to $875.1 million in 2022, then grew by 3.81% to $908.5 million in 2023, then dropped by 17.59% to $748.7 million in 2024, then grew by 17.3% to $878.3 million in 2025.
  • According to Business Quant data, Equity Average over the past three periods came in at $878.3 million, $862.2 million, and $811.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.